A ALIMENTARY TRACT AND METABOLISM

 B BLOOD AND BLOOD FORMING ORGANS

 C CARDIOVASCULAR SYSTEM

 D DERMATOLOGICALS

 G GENITO URINARY SYSTEM AND SEX HORMONES

 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

 J ANTIINFECTIVES FOR SYSTEMIC USE

 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

   L01 ANTINEOPLASTIC AGENTS

     L01A ALKYLATING AGENTS

     L01B ANTIMETABOLITES

     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

     L01X OTHER ANTINEOPLASTIC AGENTS

       L01XA Platinum compounds

       L01XB Methylhydrazines

       L01XC Monoclonal antibodies

         L01XC01 Edrecolomab

         L01XC02 Rituximab

         L01XC03 Trastuzumab

         L01XC05 Gemtuzumab ozogamicin

         L01XC06 Cetuximab

         L01XC07 Bevacizumab

         L01XC08 Panitumumab

         L01XC09 Catumaxomab

         L01XC10 Ofatumumab

         L01XC11 Ipilimumab

         L01XC12 Brentuximab vedotin

         L01XC13 Pertuzumab

         L01XC14 Trastuzumab emtansine

         L01XC15 Obinutuzumab

         L01XC16 Dinutuximab beta

         L01XC17 Nivolumab

         L01XC18 Pembrolizumab

         L01XC19 Blinatumomab

         L01XC21 Ramucirumab

         L01XC22 Necitumumab

         L01XC23 Elotuzumab

         L01XC24 Daratumumab

         L01XC25 Mogamulizumab

         L01XC26 Inotuzumab ozogamicin

         L01XC27 Olaratumab

         L01XC28 Durvalumab

         L01XC29 Bermekimab

         L01XC31 Avelumab

         L01XC32 Atezolizumab

         L01XC33 Cemiplimab

       L01XD Sensitizers used in photodynamic/radiation therapy

       L01XE Protein kinase inhibitors

       L01XX Other antineoplastic agents

       L01XY Combinations of antineoplastic agents

   L02 ENDOCRINE THERAPY

   L03 IMMUNOSTIMULANTS

   L04 IMMUNOSUPPRESSANTS

 M MUSCULO-SKELETAL SYSTEM

 N NERVOUS SYSTEM

 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

 R RESPIRATORY SYSTEM

 S SENSORY ORGANS

 V VARIOUS